Anil K. Sood, MD
Professor
The University of Texas MD Anderson Cancer Center
1155 Herman P. Pressler
Unit 1362
Houston,
TX
USA
77030
Papers:
20
Personalized surgical therapy for advanced ovarian cancer
46
Homologous recombination deficiency in uterine cancer
134
The FAK of uterine cancer: PTEN expression predicts response of uterine cancer to focal adhesion kinase inhibition
135
Molecular predictors of response to EphA2 targeted therapy in uterine cancer
155
Fuel for the fire: connecting genomics with metabolomics in ovarian cancer
159
Role of increased n-acetylaspartate levels in epithelial ovarian cancer
192
Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer
267
IL-6, VTE and ovarian clear cell carcinoma: a dangerous triad
Presentation of the Foundation for Women's Cancer Awards